Acquiring Company
Garda Therapeutics
Acquired Company
Assertio Holdings
North Brabant
Lake ForestBiotechnologyHealth CarePharmaceuticalManufacturingBiotechnologyHealth CarePharmaceuticalDescription
Garda Therapeutics has announced an agreement to acquire Assertio Holdings for $18 per share, totaling $125.1 million in cash. The deal follows a thorough strategic review and provides a premium to Assertio's stock price. The acquisition aims to maximize shareholder value and includes provisions for future performance-based payouts.
Quick answer
Garda Therapeutics is acquiring Assertio Holdings for $125.1 million, announced April 8, 2026. Garda Therapeutics is based in North Brabant, Netherlands.
- How much did Garda Therapeutics pay for Assertio Holdings?
- The reported deal value is $125.1 million.
- What does Garda Therapeutics do?
- Garda Therapeutics is focused on developing innovative therapies to treat various medical conditions.
- Where are Garda Therapeutics and Assertio Holdings based?
- Garda Therapeutics is based in North Brabant, Netherlands. Assertio Holdings is based in Lake Forest, Illinois, United States.
- Who are the decision-makers at Garda Therapeutics?
- Fundz holds 1 contact at Garda Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- ESTEVE acquires TerSera's Infusion Business Unit (May 4, 2026)
- Kopran Limited to merge with Kopran Laboratories Limited (February 27, 2026)
- Assertio acquires Garda Therapeutics in merger deal (May 5, 2026)
- Eli Lilly to acquire Ajax Therapeutics for $2.3B, $2.3B (April 27, 2026)
- Anlon Healthcare acquires Remember India Health Links (April 16, 2026)
- Merck acquires JSR Life Sciences' chromatography business (April 2, 2026)
Who to call at Garda Therapeutics, and when
When Garda Therapeutics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Garda Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Garda Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Garda Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Garda Therapeutics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Assertio Holdings?
Assertio Holdings was acquired by Garda Therapeutics, based in North Brabant. The deal was reported on April 8, 2026. Garda Therapeutics is focused on developing innovative therapies to treat various medical conditions. The company aims to improve patient outcomes through advanced pharmaceutical technologies. Garda Therapeutics is privately held and operates in Biotechnology.
When did Garda Therapeutics acquire Assertio Holdings?
Garda Therapeutics's acquisition of Assertio Holdings was reported on April 8, 2026. Garda Therapeutics has announced an agreement to acquire Assertio Holdings for $18 per share, totaling $125.1 million in cash. The deal follows a thorough strategic review and provides a premium to Assertio's stock price. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Assertio Holdings do?
Assertio is a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that make a difference in the lives of patients. It is privately held, operating in Manufacturing, and is based in Lake Forest.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.